Pasture Holdings' Earnings Rebound in FY 2024
Pasture Holdings' Earnings Rebound in FY 2024
The mask and medical supplies business also grew 300% to $201,434 (US$154,000) from $58,860 (US$45,000) in FY 2023.The company has rebounded from a net loss of US$1.3m to a net profit of US$0.6m.
该公司从130万美元的净亏损中恢复过来，实现60万美元的净利润。
Pasture Holdings rebounded from a net loss of $1.7m (US$1.3m) to a net profit of $0.73m (US$0.6m) in FY 2024.
Pasture Holdings在2024财年从170万美元（130万美元）的净亏损中恢复过来，实现73万美元（60万美元）的净利润。
Revenue for the period surged 44.9% year-on-year (YoY) to $18.3m (US$14.0m), driven by a 43..7% YoY growth in its pharmaceutical business which recorded a revenue of $18.2m (US$13.9m) with new customer acquisitions and more orders from existing customers.
该期间收入同比增长44.9%，达到1830万美元（1400万美元），其中医药业务实现了43.7%的同比增长，营业收入达到1820万美元（1390万美元），得益于新客户的获取以及现有客户的更多订单。
The mask and medical supplies business also grew 300% to $201,434 (US$154,000) from $58,860 (US$45,000) in FY 2023.
同样，口罩和医疗用品业务实现了300%的增长，从2023财年的58,860美元（45,000美元）增长至201,434美元（154,000美元）。
Meanwhile, gross profit more than doubled to $4.6m (US$3.5m) due to higher revenue and related operational efficiencies achieved.
与此同时，由于收入增长和相关运营效率的提高，毛利润增长了一倍以上，达到460万美元（350万美元）。
Pasture Holdings maintains a positive outlook amidst favourable structural trends such as the ageing global population, an enlarged cold chain warehouse capacity, and potential growth in new non-core business
Pasture Holdings对未来保持积极态度，受益于全球人口老龄化、冷链仓库容量的扩大以及新的非核心业务的潜力增长等有利结构性趋势。
